A-Alpha Bio today announced that it has been awarded a National Science Foundation Phase II Small Business Innovation Research (SBIR) grant to continue developing their AlphaSeq platform for the discovery of molecular glues.
GeekWire wrote a great summary article with more details about the award and about the potential impact of molecular glue discovery in medicine.